Ligand validation:5O80

AHR: alpha-L-arabinofuranose

AHR is a Ligand Of Interest in 5O80 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5O80_AHR_F_600	49%	28%	0.21	0.96	1.64	1.39	3	2	0	0	100%	1
5O80_AHR_B_600	49%	20%	0.199	0.947	1.95	1.6	2	3	0	0	100%	1
5O80_AHR_E_600	41%	20%	0.204	0.922	1.94	1.6	4	3	0	0	100%	1
5O80_AHR_A_600	41%	33%	0.204	0.919	1.66	1.11	2	1	0	0	100%	1
5O80_AHR_D_600	30%	29%	0.237	0.9	1.63	1.35	2	1	0	0	100%	1
5O80_AHR_C_600	21%	21%	0.279	0.891	1.71	1.74	2	3	0	0	100%	1
5O82_AHR_D_600	15%	27%	0.234	0.79	1.77	1.31	2	2	0	0	100%	0.74
5OCP_AHR_A_407	97%	42%	0.066	0.978	1.04	1.26	-	1	0	0	100%	0.5
3UG4_AHR_F_487	95%	37%	0.071	0.976	1.63	0.94	2	-	0	0	100%	1
2YDT_AHR_A_501	93%	42%	0.064	0.978	0.97	1.33	-	2	0	0	90%	0.9
2YDP_AHR_A_501	85%	49%	0.083	0.967	0.64	1.31	-	1	0	0	90%	0.9
1WD4_AHR_A_602	84%	44%	0.1	0.962	1.2	1.02	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.